Cargando…

Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia

BACKGROUND: Anal cancer is uncommon. Although uncommon, the incidence of anal cancer has increased among the general population of the United States and other countries over the past 30 years. We evaluated anal cytology in women with the history of abnormal pap smear, cervical intraepithelial neopla...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosseini, Maryam Sadat, Khosravi, Donya, Farzaneh, Farah, Ebrahimi, Abdalali, Arab, Maliheh, Ganjoie, Tahereh Ashraf, Jamdar, Farzane, Moridi, Atefeh, Chehrazi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318392/
https://www.ncbi.nlm.nih.gov/pubmed/30485943
http://dx.doi.org/10.31557/APJCP.2018.19.11.3071
_version_ 1783384866964897792
author Hosseini, Maryam Sadat
Khosravi, Donya
Farzaneh, Farah
Ebrahimi, Abdalali
Arab, Maliheh
Ganjoie, Tahereh Ashraf
Jamdar, Farzane
Moridi, Atefeh
Chehrazi, Mohammad
author_facet Hosseini, Maryam Sadat
Khosravi, Donya
Farzaneh, Farah
Ebrahimi, Abdalali
Arab, Maliheh
Ganjoie, Tahereh Ashraf
Jamdar, Farzane
Moridi, Atefeh
Chehrazi, Mohammad
author_sort Hosseini, Maryam Sadat
collection PubMed
description BACKGROUND: Anal cancer is uncommon. Although uncommon, the incidence of anal cancer has increased among the general population of the United States and other countries over the past 30 years. We evaluated anal cytology in women with the history of abnormal pap smear, cervical intraepithelial neoplasia, cervical cancer and high risk HPV for anogenital dysplasia. METHODS: In this cross-sectional study, 153 patients over the age of 21 years, referred to Imam Hossein Hospital in 1395-1396 who were being monitored due to abnormal pap smear, cervical cancer, CIN and high risk HPV, were evaluated with anal cytology for anogenital dysplasia. RESULTS: 153 patients were enrolled in four main groups. Among those with a history of abnormal pap smear (39 patients), only 25% of the patients with HSIL had abnormal anal pap smear, and the rest of them had negative anal smear. Among those with a history of CIN (61 patients), patients with CIN III, 30.8% had abnormal anal smear, while the rest had a negative anal smear. Among those with a high risk of HPV (23 patients), 50% of the patients with concurrent positive HPV 16 and 18 had anal abnormal smear. Patients with a history of cervical cancer (30 patients) who had radiotherapy with or without surgery showed a negative anal smear. The ratio of anal SIL positive of individuals with a sexual partner was only 1.9%, while this ratio was 27.3% for those with more than one partner and this difference was statistically significant (P <0.0001). 15.4% of smokers had positive anal SIL test result, while, only 2.9% non-smokers had the same result, and this difference was statistically significant (P = 0.03). 20% of the patients who had anal intercourse showed a positive anal SIL score result, compared to 1% for those who did not. This difference was statistically significant (P <0.0001). CONCLUSION: Among people with a history of abnormal cervical pap smear, CIN, cervical cancer and high-risk HPV during the last 6 months, abnormal anal tests are most commonly seen in patients who had risk factors such as anal sex, cigarette, multi partner etc. with high grade interepithelial squamous cervix such as HSIL, CIN III, HPV 16 and 18; more studies in larger sample size are needed to have the better conclusion.
format Online
Article
Text
id pubmed-6318392
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-63183922019-01-14 Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia Hosseini, Maryam Sadat Khosravi, Donya Farzaneh, Farah Ebrahimi, Abdalali Arab, Maliheh Ganjoie, Tahereh Ashraf Jamdar, Farzane Moridi, Atefeh Chehrazi, Mohammad Asian Pac J Cancer Prev Research Article BACKGROUND: Anal cancer is uncommon. Although uncommon, the incidence of anal cancer has increased among the general population of the United States and other countries over the past 30 years. We evaluated anal cytology in women with the history of abnormal pap smear, cervical intraepithelial neoplasia, cervical cancer and high risk HPV for anogenital dysplasia. METHODS: In this cross-sectional study, 153 patients over the age of 21 years, referred to Imam Hossein Hospital in 1395-1396 who were being monitored due to abnormal pap smear, cervical cancer, CIN and high risk HPV, were evaluated with anal cytology for anogenital dysplasia. RESULTS: 153 patients were enrolled in four main groups. Among those with a history of abnormal pap smear (39 patients), only 25% of the patients with HSIL had abnormal anal pap smear, and the rest of them had negative anal smear. Among those with a history of CIN (61 patients), patients with CIN III, 30.8% had abnormal anal smear, while the rest had a negative anal smear. Among those with a high risk of HPV (23 patients), 50% of the patients with concurrent positive HPV 16 and 18 had anal abnormal smear. Patients with a history of cervical cancer (30 patients) who had radiotherapy with or without surgery showed a negative anal smear. The ratio of anal SIL positive of individuals with a sexual partner was only 1.9%, while this ratio was 27.3% for those with more than one partner and this difference was statistically significant (P <0.0001). 15.4% of smokers had positive anal SIL test result, while, only 2.9% non-smokers had the same result, and this difference was statistically significant (P = 0.03). 20% of the patients who had anal intercourse showed a positive anal SIL score result, compared to 1% for those who did not. This difference was statistically significant (P <0.0001). CONCLUSION: Among people with a history of abnormal cervical pap smear, CIN, cervical cancer and high-risk HPV during the last 6 months, abnormal anal tests are most commonly seen in patients who had risk factors such as anal sex, cigarette, multi partner etc. with high grade interepithelial squamous cervix such as HSIL, CIN III, HPV 16 and 18; more studies in larger sample size are needed to have the better conclusion. West Asia Organization for Cancer Prevention 2018 /pmc/articles/PMC6318392/ /pubmed/30485943 http://dx.doi.org/10.31557/APJCP.2018.19.11.3071 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Research Article
Hosseini, Maryam Sadat
Khosravi, Donya
Farzaneh, Farah
Ebrahimi, Abdalali
Arab, Maliheh
Ganjoie, Tahereh Ashraf
Jamdar, Farzane
Moridi, Atefeh
Chehrazi, Mohammad
Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia
title Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia
title_full Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia
title_fullStr Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia
title_full_unstemmed Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia
title_short Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia
title_sort evaluation of anal cytology in women with history of abnormal pap smear, cervical intraepithelial neoplasia, cervical cancer and high risk hpv for anogenital dysplasia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318392/
https://www.ncbi.nlm.nih.gov/pubmed/30485943
http://dx.doi.org/10.31557/APJCP.2018.19.11.3071
work_keys_str_mv AT hosseinimaryamsadat evaluationofanalcytologyinwomenwithhistoryofabnormalpapsmearcervicalintraepithelialneoplasiacervicalcancerandhighriskhpvforanogenitaldysplasia
AT khosravidonya evaluationofanalcytologyinwomenwithhistoryofabnormalpapsmearcervicalintraepithelialneoplasiacervicalcancerandhighriskhpvforanogenitaldysplasia
AT farzanehfarah evaluationofanalcytologyinwomenwithhistoryofabnormalpapsmearcervicalintraepithelialneoplasiacervicalcancerandhighriskhpvforanogenitaldysplasia
AT ebrahimiabdalali evaluationofanalcytologyinwomenwithhistoryofabnormalpapsmearcervicalintraepithelialneoplasiacervicalcancerandhighriskhpvforanogenitaldysplasia
AT arabmaliheh evaluationofanalcytologyinwomenwithhistoryofabnormalpapsmearcervicalintraepithelialneoplasiacervicalcancerandhighriskhpvforanogenitaldysplasia
AT ganjoietaherehashraf evaluationofanalcytologyinwomenwithhistoryofabnormalpapsmearcervicalintraepithelialneoplasiacervicalcancerandhighriskhpvforanogenitaldysplasia
AT jamdarfarzane evaluationofanalcytologyinwomenwithhistoryofabnormalpapsmearcervicalintraepithelialneoplasiacervicalcancerandhighriskhpvforanogenitaldysplasia
AT moridiatefeh evaluationofanalcytologyinwomenwithhistoryofabnormalpapsmearcervicalintraepithelialneoplasiacervicalcancerandhighriskhpvforanogenitaldysplasia
AT chehrazimohammad evaluationofanalcytologyinwomenwithhistoryofabnormalpapsmearcervicalintraepithelialneoplasiacervicalcancerandhighriskhpvforanogenitaldysplasia